Bruker (NASDAQ:BRKR) Releases FY 2024 Earnings Guidance

Bruker (NASDAQ:BRKR) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 2.590-2.640 for the period, compared to the consensus estimate of 2.640. The company issued revenue guidance of $3.4 billion-$3.4 billion, compared to the consensus revenue estimate of $3.4 billion. Bruker also updated its FY24 guidance to $2.59-2.64 EPS.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on BRKR. The Goldman Sachs Group decreased their price target on Bruker from $72.00 to $60.00 and set a sell rating for the company in a research report on Tuesday, July 9th. Citigroup lowered their target price on Bruker from $95.00 to $80.00 and set a buy rating on the stock in a research note on Wednesday, July 10th. Jefferies Financial Group assumed coverage on shares of Bruker in a research report on Monday, June 3rd. They set a buy rating and a $85.00 price target for the company. TD Cowen lowered their price objective on shares of Bruker from $74.00 to $72.00 and set a hold rating on the stock in a research report on Wednesday. Finally, StockNews.com downgraded shares of Bruker from a buy rating to a hold rating in a research report on Tuesday, May 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Bruker has an average rating of Hold and an average target price of $80.80.

Bruker Price Performance

NASDAQ BRKR traded down $1.32 during trading on Friday, reaching $62.00. The company’s stock had a trading volume of 1,362,202 shares, compared to its average volume of 1,034,237. The firm has a fifty day moving average of $64.22 and a 200 day moving average of $75.58. Bruker has a one year low of $53.79 and a one year high of $94.86. The stock has a market capitalization of $9.01 billion, a PE ratio of 22.55, a P/E/G ratio of 2.39 and a beta of 1.20. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.81 and a quick ratio of 0.91.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, hitting analysts’ consensus estimates of $0.52. The business had revenue of $800.70 million during the quarter, compared to analysts’ expectations of $799.44 million. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The business’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.50 EPS. Analysts expect that Bruker will post 2.66 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 17th. Shareholders of record on Monday, June 3rd were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend was Monday, June 3rd. Bruker’s dividend payout ratio is currently 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.